LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer Bringing the Total Raised for the Current Class of 4Catalyzer Companies to a Quarter-Billion […]
Featured Posts
Company to focus on pipeline of Pentarins™ as a unique and promising approach to treating solid tumor cancers Lead drug candidate PEN-221 targeting neuroendocrine and small cell lung cancers to […]
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products today announced, through its wholly owned subsidiary, […]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company is stopping its Phase 2 clinical study of the investigational monoclonal antibody simtuzumab among patients with idiopathic pulmonary […]
Strategic agreement with Kedrion for clinical development and marketing Plans to file a BLA with the FDA in mid-2016 NESS ZIONA, Israel–(BUSINESS WIRE)–Kamada Ltd. (KMDA) (KMDA.TA), a plasma-derived protein […]
Sales and Marketing: IMS projects narrowing use gap, slowing med spend growth over next five years
Analysts, Autoimmune Disorders, Behavioral Changes, December 2015, Drug Spending, Electronic Health Records, EMR, Forecasts, Generics, Health, Heart Disease, Hepatitis, Hepatitis C, Hepatitis C Infections, Innovation, Issue Archives, Mobile Health, Oncology, Population, Prescriptions, R&D, Rare Diseases, Studies, Tablets, Technology, Therapeutics, WearablesMore than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows, according to research by the IMS Institute for Healthcare Informatics.
Company Also Bolsters Board of Directors and Scientific Advisory Board with Outstanding Leaders BOSTON–(BUSINESS WIRE)–SQZ Biotech (SQZ) announced today a partnership with Roche to develop a cell therapy platform that […]
Zymeworks Announces Antibody Fc Engineering Collaboration and License Agreement with GSK
Autoimmune, Autoimmune Disease, Autoimmune Diseases, Bi-Specific Antibodies, Biotherapeutics, Business, Collaboration, Collaborations, Health, Immune Response, Inflammatory Diseases, Licensing, Licensing, Monoclonal Antibodies, Monoclonal Antibodies, Oncology, R&D, TechnologyVANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. today announced that it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK) for the research, development, and commercialization of novel Fc-engineered monoclonal […]
Pharmaceutical and Biotechnology Companies Can Now Digitally Transform Therapeutic Innovation VELIZY-VILLACOUBLAY, France — November 16, 2015 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in […]
Boehringer Ingelheim Will Invest 11 Billion Euros in Research and Development in the Next Five Years to Accelerate the Discovery of Next Generation Medical Breakthroughs
Biomedical, Cardimetabolic, Central Nervous System, Drug Discovery, Immunology, Innovation, Irritable Bowel Syndrome, Oncology, Partnership, Partnerships, R&D, Respiratory, Start-Ups, Start-ups, Startups11 billion euro R&D programme through 2020, with 5 billion euro dedicated to pre-clinical R&D and 1.5 billion euro planned for cooperation with external partners New partnerships with the […]